| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |




From the University of Texas Health Science Center at San Antonio,
*
San Antonio, Texas; the 81 Medical Defense Group,
Keesler Hospital, Keesler Air Force Base, Mississippi; The Audie L. Murphy Memorial Veterans Hospital,
San Antonio, Texas; and the University of Michigan Medical Center,
Ann Arbor, Michigan
In typical cases of infectious mononucleosis (IM), lymphoid
tissue is rarely submitted for pathological examination. When lymphoid
tissues from IM cases are examined, the histological appearance
of IM may be difficult to distinguish from malignant lymphoma. The
purpose of this study was to address the utility of clinical molecular
assays for T and B cell clonality in distinguishing IM from lymphoid
malignancy. DNA was recovered from paraffin-embedded archival lymphoid
tissues of 18 cases of IM and 13 control cases representing other
reactive lymphoid hyperplasias. T cell receptor
(TCR-
) and
immunoglobulin heavy chain (IgH) gene rearrangements were assayed using
our standard clinical polymerase chain reaction procedures targeting
each of the four functional variable (V) families and the three joining
(J) families of the TCR-
gene, and framework III of the IgH
gene, respectively. In 17 of 18 cases of IM, no
monoclonal T or B cell populations were detectable. One case,
the only spleen specimen in the study, had an oligoclonal
pattern of TCR-
rearrangements. The control cases representing other
reactive hyperplasias also lacked monoclonality. The assays used were
sensitive to clonal populations as small as 5% of cells. In this case
series, no monoclonal lymphoid populations were identified in
any case of IM. This finding suggests that molecular studies are useful
in distinguishing IM from lymphoid neoplasms.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |